Your browser doesn't support javascript.
loading
A phase I/II randomized, double-blinded, placebo-controlled trial of a self-amplifying Covid-19 mRNA vaccine.
Low, Jenny G; de Alwis, Ruklanthi; Chen, Shiwei; Kalimuddin, Shirin; Leong, Yan Shan; Mah, Tania Ken Lin; Yuen, Natalene; Tan, Hwee Cheng; Zhang, Summer L; Sim, Jean X Y; Chan, Yvonne F Z; Syenina, Ayesa; Yee, Jia Xin; Ong, Eugenia Z; Sekulovich, Rose; Sullivan, Brian B; Lindert, Kelly; Sullivan, Sean M; Chivukula, Pad; Hughes, Steven G; Ooi, Eng Eong.
Afiliación
  • Low JG; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, 8 College Road, 169857, Singapore, Singapore.
  • de Alwis R; Department of Infectious Diseases, Singapore General Hospital, 169608, Singapore, Singapore.
  • Chen S; Viral Research and Experimental Medicine Center, SingHealth Duke-NUS Academic Medical Center, Singapore, Singapore.
  • Kalimuddin S; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, 8 College Road, 169857, Singapore, Singapore.
  • Leong YS; Viral Research and Experimental Medicine Center, SingHealth Duke-NUS Academic Medical Center, Singapore, Singapore.
  • Mah TKL; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, 8 College Road, 169857, Singapore, Singapore.
  • Yuen N; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, 8 College Road, 169857, Singapore, Singapore.
  • Tan HC; Department of Infectious Diseases, Singapore General Hospital, 169608, Singapore, Singapore.
  • Zhang SL; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, 8 College Road, 169857, Singapore, Singapore.
  • Sim JXY; Viral Research and Experimental Medicine Center, SingHealth Duke-NUS Academic Medical Center, Singapore, Singapore.
  • Chan YFZ; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, 8 College Road, 169857, Singapore, Singapore.
  • Syenina A; Viral Research and Experimental Medicine Center, SingHealth Duke-NUS Academic Medical Center, Singapore, Singapore.
  • Yee JX; Viral Research and Experimental Medicine Center, SingHealth Duke-NUS Academic Medical Center, Singapore, Singapore.
  • Ong EZ; Department of Biological Sciences, Nanyang Technological University, 639798, Singapore, Singapore.
  • Sekulovich R; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, 8 College Road, 169857, Singapore, Singapore.
  • Sullivan BB; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, 8 College Road, 169857, Singapore, Singapore.
  • Lindert K; Department of Infectious Diseases, Singapore General Hospital, 169608, Singapore, Singapore.
  • Sullivan SM; Department of Infectious Diseases, Singapore General Hospital, 169608, Singapore, Singapore.
  • Chivukula P; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, 8 College Road, 169857, Singapore, Singapore.
  • Hughes SG; Viral Research and Experimental Medicine Center, SingHealth Duke-NUS Academic Medical Center, Singapore, Singapore.
  • Ooi EE; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, 8 College Road, 169857, Singapore, Singapore.
NPJ Vaccines ; 7(1): 161, 2022 Dec 13.
Article en En | MEDLINE | ID: mdl-36513697
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: NPJ Vaccines Año: 2022 Tipo del documento: Article País de afiliación: Singapur
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: NPJ Vaccines Año: 2022 Tipo del documento: Article País de afiliación: Singapur